BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

57 related articles for article (PubMed ID: 23312904)

  • 1. Gold-nanobeacons for simultaneous gene specific silencing and intracellular tracking of the silencing events.
    Conde J; Rosa J; de la Fuente JM; Baptista PV
    Biomaterials; 2013 Mar; 34(10):2516-23. PubMed ID: 23312904
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Molecular photoacoustic tomography with colloidal nanobeacons.
    Pan D; Pramanik M; Senpan A; Yang X; Song KH; Scott MJ; Zhang H; Gaffney PJ; Wickline SA; Wang LV; Lanza GM
    Angew Chem Int Ed Engl; 2009; 48(23):4170-3. PubMed ID: 19418503
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Gold-nanobeacons for gene therapy: evaluation of genotoxicity, cell toxicity and proteome profiling analysis.
    Conde J; Larguinho M; Cordeiro A; Raposo LR; Costa PM; Santos S; Diniz MS; Fernandes AR; Baptista PV
    Nanotoxicology; 2014 Aug; 8(5):521-32. PubMed ID: 23642008
    [TBL] [Abstract][Full Text] [Related]  

  • 4. In vivo tumor targeting via nanoparticle-mediated therapeutic siRNA coupled to inflammatory response in lung cancer mouse models.
    Conde J; Tian F; Hernández Y; Bao C; Cui D; Janssen KP; Ibarra MR; Baptista PV; Stoeger T; de la Fuente JM
    Biomaterials; 2013 Oct; 34(31):7744-53. PubMed ID: 23850099
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Epidermal growth factor alters silica nanoparticle uptake and improves gold-nanoparticle-mediated gene silencing in A549 cells.
    Susnik E; Bazzoni A; Taladriz-Blanco P; Balog S; Moreno-Echeverri AM; Glaubitz C; Oliveira BB; Ferreira D; Baptista PV; Petri-Fink A; Rothen-Rutishauser B
    Front Nanotechnol; 2023 Jul; 5():1220514. PubMed ID: 37954478
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Exploring
    Roma-Rodrigues C; Fernandes AR; Baptista PV
    Pharmaceutics; 2023 Feb; 15(3):. PubMed ID: 36986603
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Using gold nanobeacons as a theranostic technique to recognize, detect, and inhibit specific nucleic acids.
    Sousa DP; Conde J
    STAR Protoc; 2022 Dec; 3(4):101916. PubMed ID: 36595910
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Gold Nanoconjugates for miRNA Modulation in Cancer Therapy: From miRNA Silencing to miRNA Mimics.
    Sousa DP; Conde J
    ACS Mater Au; 2022 Nov; 2(6):626-640. PubMed ID: 36397876
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Gold Nanoparticles for Vectorization of Nucleic Acids for Cancer Therapeutics.
    Ferreira D; Fontinha D; Martins C; Pires D; Fernandes AR; Baptista PV
    Molecules; 2020 Jul; 25(15):. PubMed ID: 32751935
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Gene Therapy in Cancer Treatment: Why Go Nano?
    Roma-Rodrigues C; Rivas-García L; Baptista PV; Fernandes AR
    Pharmaceutics; 2020 Mar; 12(3):. PubMed ID: 32151052
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Gold Nanoparticles in Conjunction with Nucleic Acids as a Modern Molecular System for Cellular Delivery.
    Graczyk A; Pawlowska R; Jedrzejczyk D; Chworos A
    Molecules; 2020 Jan; 25(1):. PubMed ID: 31947834
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Nucleic-Acid Structures as Intracellular Probes for Live Cells.
    Samanta D; Ebrahimi SB; Mirkin CA
    Adv Mater; 2020 Apr; 32(13):e1901743. PubMed ID: 31271253
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Capturing intracellular oncogenic microRNAs with self-assembled DNA nanostructures for microRNA-based cancer therapy.
    Liu Q; Wang D; Yuan M; He BF; Li J; Mao C; Wang GS; Qian H
    Chem Sci; 2018 Oct; 9(38):7562-7568. PubMed ID: 30319757
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Assessment of Gold Nanoparticles-Inhibited Cytochrome P450 3A4 Activity and Molecular Mechanisms Underlying Its Cellular Toxicity in Human Hepatocellular Carcinoma Cell Line C3A.
    Choi K; Joo H
    Nanoscale Res Lett; 2018 Sep; 13(1):279. PubMed ID: 30203228
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Measuring DNA hybridization using fluorescent DNA-stabilized silver clusters to investigate mismatch effects on therapeutic oligonucleotides.
    de Bruin D; Bossert N; Aartsma-Rus A; Bouwmeester D
    J Nanobiotechnology; 2018 Apr; 16(1):37. PubMed ID: 29622040
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Photothermal enhancement of chemotherapy in breast cancer by visible irradiation of Gold Nanoparticles.
    Mendes R; Pedrosa P; Lima JC; Fernandes AR; Baptista PV
    Sci Rep; 2017 Sep; 7(1):10872. PubMed ID: 28883606
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Gold Nanoparticles for BCR-ABL1 Gene Silencing: Improving Tyrosine Kinase Inhibitor Efficacy in Chronic Myeloid Leukemia.
    Vinhas R; Fernandes AR; Baptista PV
    Mol Ther Nucleic Acids; 2017 Jun; 7():408-416. PubMed ID: 28624216
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Nanoparticles as Theranostic Vehicles in Experimental and Clinical Applications-Focus on Prostate and Breast Cancer.
    Elgqvist J
    Int J Mol Sci; 2017 May; 18(5):. PubMed ID: 28531102
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Gold Nanotheranostics: Proof-of-Concept or Clinical Tool?
    Pedrosa P; Vinhas R; Fernandes A; Baptista PV
    Nanomaterials (Basel); 2015 Nov; 5(4):1853-1879. PubMed ID: 28347100
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Gold Nanobeacons for Tracking Gene Silencing in Zebrafish.
    Cordeiro M; Carvalho L; Silva J; Saúde L; Fernandes AR; Baptista PV
    Nanomaterials (Basel); 2017 Jan; 7(1):. PubMed ID: 28336844
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.